Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02088099 · ClinicalTrials.gov registry record · NA

Mayo Clinic Traumatic Brain Injury Model System Center: The CONNECT Trial

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
426
Enrollment target

NCT02088099: Completed NA study, sponsored by Mayo Clinic.

NCT02088099 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 426 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02088099, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
426 participants
Enrollment target

Study Summary

Mayo Clinic has been funded by the National Institute on Disability Independent Living \& Rehabilitation Research (NIDILRR) as a Traumatic Brain Injury (TBI) Model System Center continuously since 1998. We have successfully competed for this funding because we consistently produce high quality research and because we provide comprehensive team-based rehabilitation services to people with TBI and their families over the continuum of care that is associated with superior outcomes. Lack of access to specialized TBI care is the most common need identified by individuals after they are hospitalized for TBI. The upper Midwest has some of the highest populations of rural dwellers, the elderly, and Native Americans, all of whom have a high risk for TBI and are more likely to have limited access to rehabilitation services after acute care. Explosive advances in communication technology have brought tele-medicine to the forefront of health care. The CONNECT trial will test the effectiveness of using modern technologies - such as phone consultation and other telehealth communication systems - to deliver specialized brain rehabilitation resources remotely to patients and providers in the upper Midwest. The groups targeted by the CONNECT trial are: * Individuals recently hospitalized with TBI; * Their families; * Their local health care and other providers (primary care providers, psychologists, therapists, social service providers, job counselors). The CONNECT trial is the first study of this scope - in 4 upper Midwest states (MN, IA, ND, and SD), 3 health systems (Mayo Clinic, Altru Health System in ND, Regional Health in SD), and 2 state Departments of Health (IA, MN) - using electronic technology to see if outcome can be improved by providing care with no face-to-face contact. The trial will study whether outcomes over three years are different in the group receiving this remotely provided model of care compared to a matched group that receives usual care in their communi

Primary Outcome

TBI-QOL is a recently developed Computer Assisted Telephone Interview (CATI) tool that provides psychometrically sound and clinically relevant health-related patient-reported quality of life measurement specific to TBI. This scale is being used by the VA Research and Development Programs and will soon be a variable in the TBIMS National Database. TBI-QOL efficiently measures domains of depression, anxiety, fatigue and pain, using fewer items than scales measuring similar constructs. Responses fo

Interventions

  • OTHER Treatment as usual
  • OTHER Complex clinical intervention

Trial Details

FieldValue
Enrollment Target 426 participants
Start Date 2014-03
Est. Completion 2018-12
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT02088099 record still lists

NCT02088099 is an interventional study that assigns participants to a tested intervention. The registered 426 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).

The record links to 0 conditions, and to 2 interventions - of which Treatment as usual is the first listed.

NCT02088099 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02088099 about?

NCT02088099 is a clinical study titled "Mayo Clinic Traumatic Brain Injury Model System Center: The CONNECT Trial". Mayo Clinic has been funded by the National Institute on Disability Independent Living \& Rehabilitation Research (NIDILRR) as a Traumatic Brain Injury (TBI) Model System Center continuously since 1998. We have successfully competed for this funding because we consistently produce high quality resea...

What is the current status of trial NCT02088099?

This trial is currently completed. It is a NA study. The enrollment target is 426 participants. The study started on 2014-03. Estimated completion is 2018-12.

What interventions are being tested in trial NCT02088099?

The interventions under investigation include: Treatment as usual (OTHER), Complex clinical intervention (OTHER).

Who is sponsoring clinical trial NCT02088099?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02088099's enrollment target sits among peer trials

426 236th of 2000 higher than 1,765 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06790784 · 426 participants · Phase 3

    Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR

  • NCT04265430 · 425 participants · Phase 4

    Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors

  • NCT04278690 · 425 participants · NA

    Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit

  • NCT05321368 · 425 participants · NA

    A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02088099, the US trial registry maintained by the National Library of Medicine. NCT02088099 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.